JRP
TNYA icon

Jasper Ridge Partners’s Tenaya Therapeutics TNYA Stock Holding History

Jasper Ridge Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,250
Closed -$7.1K – 157
2026
Q1 		$7.1K Hold
10,250
– – ﹤0.01% 143
2025
Q4 		$7.29K Hold
10,250
– – ﹤0.01% 140
2025
Q3 		$16.6K Hold
10,250
– – ﹤0.01% 144
2025
Q2 		$6.26K Hold
10,250
– – ﹤0.01% 148
2025
Q1 		$5.84K Hold
10,250
– – ﹤0.01% 148
2024
Q4 		$14.7K Hold
10,250
– – ﹤0.01% 144
2024
Q3 		$19.8K Hold
10,250
– – ﹤0.01% 143
2024
Q2 		$31.8K Hold
10,250
– – ﹤0.01% 145
2024
Q1 		$53.6K Hold
10,250
– – ﹤0.01% 146
2023
Q4 		$33.2K Sell
10,250
-52,718
-84% -$114K ﹤0.01% 145
2023
Q3 		$161K Hold
62,968
– – 0.01% 128
2023
Q2 		$370K Hold
62,968
– – 0.02% 110
2023
Q1 		$179K Hold
62,968
– – 0.01% 135
2022
Q4 		$127K Buy
62,968
+13,573
+27% +$33.1K 0.01% 137
2022
Q3 		$143K Buy
49,395
+5,000
+11% +$23.3K 0.01% 137
2022
Q2 		$250K Hold
44,395
– – 0.02% 122
2022
Q1 		$523K Hold
44,395
– – 0.03% 111
2021
Q4 		$841K Buy
44,395
+1,000
+2% +$21.8K 0.03% 102
2021
Q3 		$896K Buy
+43,395
New +$932K 0.04% 105

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jasper Ridge Partners's TNYA Position: Q2 2026 in Review

Jasper Ridge Partners sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 10,250 shares — an estimated $7.1K sold.

Jasper Ridge Partners first reported a position in TNYA in Q3 2021 and held it in 19 quarters. The position peaked at $896K in Q3 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Jasper Ridge Partners reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jasper Ridge Partners sold 10,250 Tenaya Therapeutics shares in Q2 2026, an estimated $7.1K.
  • Jasper Ridge Partners first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 19 quarters.
  • Jasper Ridge Partners's Tenaya Therapeutics position peaked at $896K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.